MedPath

E-Plus Eurycoma LGF Extract 100mg Tablet

Registration Number: MAL24116112T

Approved
Approval ID

0c8c6f43cd7275cf

Registration Number

MAL24116112T

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types10 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (10)

200 TabletsAvailable
Package Size: 200 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
180 TabletsAvailable
Package Size: 180 Tablets
Status: NPRA Approved
250 TabletsAvailable
Package Size: 250 Tablets
Status: NPRA Approved
300 TabletsAvailable
Package Size: 300 Tablets
Status: NPRA Approved
10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved
20 TabletsAvailable
Package Size: 20 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Eurycoma longifoliaActive
Monograph: eurycoma longifolia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

E-Plus Eurycoma LGF Extract 100mg Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform